HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beauty Beverage Makers Chart Choppy Regulatory Waters, FDA Suggests

This article was originally published in The Rose Sheet

Executive Summary

Marketers of skin-care and beauty beverages should be wary of presenting their products in a way that could place them under the purview of food regulations in light of a recent FDA draft guidance that has ruffled some feathers in the industry

You may also be interested in...



Noah's Naturals Ingestible Anti-Aging Elixir Winning Over Mass Retailers

Noah's Naturals is expanding to new mass retail locations with its revamped natural skin-care line featuring an anti-aging beverage the brand credits with "getting its foot in the door.

Westerners Increasingly Open To Ingestible Skin Care, GliSODin Skin Nutrients

U.S. consumers are coming around to the idea of nutricosmetics, or ingestible products formulated to offer beauty and skin health benefits, according to Isocell, manufacturer of GliSODin Skin Nutrients

MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In

The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016816

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel